Publicis Groupe agreed to pay a $350 million settlement over claims that its misleading marketing of opioids contributed to the lethal opioid epidemic in the US.
Court documents released under Purdue Pharma's bankruptcy proceedings reveal that consulting firm McKinsey & Company advised its client to pay rebates to OxyContin distributors whenever an overdose case could be traced back to abuse of the controversial opioid pill.
The purpose of these bribes or bonuses was to help "speed up" Purdue's sales of the deadly drug, thereby producing greater profits for the pharmaceutical giant amid increasing scrutiny over its illicit sales and marketing practices.
In a 2017 presentation, McKinsey advised Purdue to compensate OxyContin distributors for harm associated with selling the drug to help boost sales. These distributors include pharmacy chain CVS Health and Anthem, which are two of McKinsey's largest clients.
McKinsey made estimates of how many people would likely overdose or get hooked on OxyContin, and recommended Purdue pay rebates for these “events” to continue making a windfall from illicit sales of the drug.
Each of the 2,484 OxyContin overdose or addiction cases traced through these respective distributors were reportedly paid $14,810 per case, netting the distributors $36.8 million in kickbacks. However, CVS and Anthem claim they never actually received these "refunds"
To try to cover their tracks, McKinsey's senior partners discussed a year later the importance of "deleting all our documents and emails." This suggestion was made after the state of Massachusetts filed a lawsuit against a former Purdue board member for the role she played in fueling the opioid crisis.
Publicis is also a partner of the World Economic Forum. To defend health we must open our minds and differentiate truth from lies, fight against misinformation and the loss of freedom of expression that many parents have, among them NewsGuard received a large part of its initial capital from Publicis (which represents the majority of the world's leading pharmaceutical companies) and given that much of its revenue comes from the pharmaceutical industry, it is not unreasonable to assume that Publicis could influence the "fairness" of NewsGuard. ”, as they rate the websites of Pharma competitors, such as “anti-vaxx” websites. NewsGuard's health-related service called HealthGuard is also partnered with an organization calling itself the Center for Countering Digital Hate (CCDH),
A federal appeals court cleared the way for the maker of OxyContin to resolve thousands of lawsuits related to the opioid epidemic while protecting Purdue Pharma's wealthy owners, the Sackler family, from future lawsuits.
Under the plan approved by the Second U.S. Circuit Court of Appeals in New York, members of the wealthy Sackler family would relinquish ownership of Stamford, Connecticut-based Purdue, which would become a new company known as Knoa , whose profits would be sent to a fund to prevent and treat addiction.
Family members would also contribute between $5.5 billion and $6 billion in cash over time, or about half of what the court considered their collective fortune, much of it held overseas. A portion of that money — at least $750 million — will go to individual victims of the opioid crisis and their survivors. Payments are expected to range between $3,500 and $48,000
Court documents released under Purdue Pharma's bankruptcy proceedings reveal that consulting firm McKinsey & Company advised its client to pay rebates to OxyContin distributors whenever an overdose case could be traced back to abuse of the controversial opioid pill.
The purpose of these bribes or bonuses was to help "speed up" Purdue's sales of the deadly drug, thereby producing greater profits for the pharmaceutical giant amid increasing scrutiny over its illicit sales and marketing practices.
In a 2017 presentation, McKinsey advised Purdue to compensate OxyContin distributors for harm associated with selling the drug to help boost sales. These distributors include pharmacy chain CVS Health and Anthem, which are two of McKinsey's largest clients.
McKinsey made estimates of how many people would likely overdose or get hooked on OxyContin, and recommended Purdue pay rebates for these “events” to continue making a windfall from illicit sales of the drug.
Each of the 2,484 OxyContin overdose or addiction cases traced through these respective distributors were reportedly paid $14,810 per case, netting the distributors $36.8 million in kickbacks. However, CVS and Anthem claim they never actually received these "refunds"
To try to cover their tracks, McKinsey's senior partners discussed a year later the importance of "deleting all our documents and emails." This suggestion was made after the state of Massachusetts filed a lawsuit against a former Purdue board member for the role she played in fueling the opioid crisis.
https://www.rt.com/usa/508095-mckinsey-oxycontin-overdose-rebates/ (2020).--
Publicis is also a partner of the World Economic Forum. To defend health we must open our minds and differentiate truth from lies, fight against misinformation and the loss of freedom of expression that many parents have, among them NewsGuard received a large part of its initial capital from Publicis (which represents the majority of the world's leading pharmaceutical companies) and given that much of its revenue comes from the pharmaceutical industry, it is not unreasonable to assume that Publicis could influence the "fairness" of NewsGuard. ”, as they rate the websites of Pharma competitors, such as “anti-vaxx” websites. NewsGuard's health-related service called HealthGuard is also partnered with an organization calling itself the Center for Countering Digital Hate (CCDH),
https://thetruthaboutvaccines.com/ap-article-lies/ .----
A federal appeals court cleared the way for the maker of OxyContin to resolve thousands of lawsuits related to the opioid epidemic while protecting Purdue Pharma's wealthy owners, the Sackler family, from future lawsuits.
Under the plan approved by the Second U.S. Circuit Court of Appeals in New York, members of the wealthy Sackler family would relinquish ownership of Stamford, Connecticut-based Purdue, which would become a new company known as Knoa , whose profits would be sent to a fund to prevent and treat addiction.
Family members would also contribute between $5.5 billion and $6 billion in cash over time, or about half of what the court considered their collective fortune, much of it held overseas. A portion of that money — at least $750 million — will go to individual victims of the opioid crisis and their survivors. Payments are expected to range between $3,500 and $48,000
https://apnews.com/article/opioid-crisis-purdue-settlement-bankruptcy-sackler-9d1f39c52d8d0f4f0c79960d930a5b84 (2023).---